Azathioprine-induced hepatotoxicity in a patient with Crohn’s disease
Keywords:
Crohn's Disease. Azathioprine. Hepatotoxicity. Nodular regenerative hiperplasia. Portal hipertension.Abstract
Immunosuppressive drugs are among the pharmacological groups with the most theoretical potential to induce adverse reactions, including hepatic reactions. We report the case of a 35-year-old patient with Crohn's disease treated with azathioprine for steroid dependence which, after a hepatic biopsy, was diagnosed with nodular regenerative hyperplasia secondary to this treatment.
Downloads
References
1. LICHTENSTEIN GR, ABREU MT, COHEN R, TREMAINE W. American Gastroenterological Association Institute technical review on corticosteroids, inmunomodulators, and infliximab in inflammatory bowel disease. Gastroenterology 2006; 130: 940-987.
https://doi.org/10.1053/j.gastro.2006.01.048
2. TOSCANO E, COTTA J, ROBLES M, LUCENA I, ANDRADE R. Hepatotoxicity induced by new immunosuppressants. Gastroenterol Hepatol 2010; 33: 54-65.
https://doi.org/10.1016/j.gastrohep.2009.07.003
3. GISBERT JP, GONZÁLEZ-LAMA Y, MATÉ J. Thiopurine-induced liver injury in patients with inflamatory bowel disease: a sistematyc review. Am J Gastroenterol 2007; 102: 1518-1527.
https://doi.org/10.1111/j.1572-0241.2007.01187.x
4. SHAYE OA, YADEGARI M, ABREU MT, POORDAD F, SIMON K, MARTIN, et al. Hepatotoxicity of 6-mercaptopurine (6-MP) and azathioprine (AZA) in adult IBD patients. Am J Gastroenterol 2007; 102: 2488-2494.
https://doi.org/10.1111/j.1572-0241.2007.01515.x
5. TAPNER MJ, JONES BE, WU WM, FARRELL GC. Toxicity of low dose azathioprine and 6-mercaptupurine in rat hepatocytes. Roles of xanthine oxidase and mitochondrial injury. J Hepatol 2004; 40: 454-463.
https://doi.org/10.1016/j.jhep.2003.11.024
6. ARNOTT ID, GHOSH S. Portal hypertension in the presence of minimal liver damage in Crohn's disease on long-term azathioprine: possible endothelial cell injury. Eur J Gastroenterol Hepatol 2000; 12: 569-573.
https://doi.org/10.1097/00042737-200012050-00016
7. SEKSIK P, MARY JY, BEAUGERIE L, LÉMANN M, COLOMBEL JF, VERNIER-MASSOUILLE G, COSNES J. Incidence of nodular regenerative hyperplasia in inflammatory bowel disease patients treated with azathioprine. Inflamm Bowel Dis 2011; 17: 565-572.
https://doi.org/10.1002/ibd.21330
8. NAER AH, VAN HAELST U, YAP SH. Nodular regenerative hyperplasia of the liver: an important cause of portal hypertension in non-cirrhotic patients. J Hepatol 1991; 12: 94-99.
https://doi.org/10.1016/0168-8278(91)90916-Y
9. VERNIER-MASSOUILLE G, COSNES J, LEMANN M, MARTEAU P, REINISCH W, LAHARIE D et al. Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine. Gut 2007; 56: 1404-1409.
https://doi.org/10.1136/gut.2006.114363
10. SEIDERER J, ZECH CJ, DIEBOLD J, SCHOENBERG SO, BRAND S, TILLACK C et al. Nodular regenerative hyperplasia: a reversible entity associated with azathioprine therapy. Eur J Gastroenterol Hepatol 2006; 18: 553-555.
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2013 Anales del Sistema Sanitario de Navarra
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
La revista Anales del Sistema Sanitario de Navarra es publicada por el Departamento de Salud del Gobierno de Navarra (España), quien conserva los derechos patrimoniales (copyright ) sobre el artículo publicado y favorece y permite la difusión del mismo bajo licencia Creative Commons Reconocimiento-CompartirIgual 4.0 Internacional (CC BY-SA 4.0). Esta licencia permite copiar, usar, difundir, transmitir y exponer públicamente el artículo, siempre que siempre que se cite la autoría y la publicación inicial en Anales del Sistema Sanitario de Navarra, y se distinga la existencia de esta licencia de uso.
